Skip to main content
. Author manuscript; available in PMC: 2014 Dec 7.
Published in final edited form as: Stat Med. 2014 Jan 28;33(12):1990–2003. doi: 10.1002/sim.6097

Table V.

True (toxicity, efficacy) probabilities for scenarios 1–9 for six treatment combinations.

Scenario Doses of

A
True (toxicity, efficacy) rates

Doses of B

1 2 3
1 2 (0.10, 0.20) (0.15, 0.40) (0.45, 0.60)
1 (0.05, 0.10) (0.15, 0.30) (0.20, 0.50)
2 2 (0.10, 0.20) (0.20, 0.40) (0.50, 0.55)
1 (0.05, 0.10) (0.15, 0.30) (0.40, 0.50)
3 2 (0.10, 0.20) (0.15, 0.30) (0.20, 0.50)
1 (0.05, 0.10) (0.10, 0.20) (0.15, 0.40)
4 2 (0.10, 0.30) (0.40, 0.50) (0.60, 0.60)
1 (0.05, 0.20) (0.20, 0.40) (0.50, 0.55)
5 2 (0.10, 0.20) (0.20, 0.40) (0.50, 0.50)
1 (0.05, 0.10) (0.15, 0.30) (0.20, 0.40)
6 2 (0.40, 0.44) (0.72, 0.58) (0.90, 0.71)
1 (0.23, 0.36) (0.40, 0.49) (0.59, 0.62)
7 2 (0.24, 0.40) (0.56, 0.60) (0.83, 0.78)
1 (0.13, 0.32) (0.25, 0.50) (0.42, 0.68)
8 2 (0.15, 0.30) (0.25, 0.41) (0.40, 0.54)
1 (0.11, 0.15) (0.15, 0.22) (0.20, 0.31)
9 2 (0.15, 0.17) (0.19, 0.33) (0.23, 0.55)
1 (0.12, 0.10) (0.15, 0.22) (0.19, 0.39)

Combinations with acceptable toxicity (i.e., ≤ ϕT = 30%) and high efficacy (i.e., ≥ ϕE = 20%) are defined as ‘target combinations’ and are indicated in boldface type.